- Previous Close
7.25 - Open
7.29 - Bid 7.23 x 200
- Ask 9.24 x 100
- Day's Range
7.20 - 7.29 - 52 Week Range
6.21 - 9.81 - Volume
63,443 - Avg. Volume
111,144 - Market Cap (intraday)
287.322M - Beta (5Y Monthly) 1.51
- PE Ratio (TTM)
25.96 - EPS (TTM)
0.28 - Earnings Date May 5, 2025 - May 9, 2025
- Forward Dividend & Yield --
- Ex-Dividend Date --
- 1y Target Est
12.83
Viemed Healthcare, Inc., through its subsidiaries, provides home medical equipment (HME) and post-acute respiratory healthcare services in the United States. The company provides respiratory disease management solutions, including treatment of chronic obstructive pulmonary disease (COPD), which include non-invasive ventilation, percussion vests, and other therapies; and invasive and non-invasive ventilation and related equipment and supplies to patients suffering from COPD. It also sells and rents HME devices, such as non-invasive and invasive ventilators, positive airway pressure (PAP) machines, durable medical equipment, percussion vests, oxygen concentrators, and other medical equipment. In addition, the company provides neuromuscular care and oxygen therapy services; and sleep apnea management that provides sleep solutions and/or equipment, such as PAP, automatic continuous positive airway pressure, and bi-level positive airway pressure machines. Further, the company offers in home sleep apnea testing services, as well as healthcare staffing and recruitment services. Viemed Healthcare, Inc. was founded in 2006 and is headquartered in Lafayette, Louisiana.
www.viemed.comRecent News: VMD
View MorePerformance Overview: VMD
Trailing total returns as of 3/28/2025, which may include dividends or other distributions. Benchmark is S&P 500 (^GSPC) .
YTD Return
1-Year Return
3-Year Return
5-Year Return
Compare To: VMD
Select to analyze similar companies using key performance metrics; select up to 4 stocks.
Statistics: VMD
View MoreValuation Measures
Market Cap
287.32M
Enterprise Value
276.65M
Trailing P/E
25.96
Forward P/E
--
PEG Ratio (5yr expected)
--
Price/Sales (ttm)
1.32
Price/Book (mrq)
2.19
Enterprise Value/Revenue
1.23
Enterprise Value/EBITDA
6.54
Financial Highlights
Profitability and Income Statement
Profit Margin
5.02%
Return on Assets (ttm)
6.49%
Return on Equity (ttm)
9.23%
Revenue (ttm)
224.26M
Net Income Avi to Common (ttm)
11.27M
Diluted EPS (ttm)
0.28
Balance Sheet and Cash Flow
Total Cash (mrq)
17.54M
Total Debt/Equity (mrq)
5.15%
Levered Free Cash Flow (ttm)
2.22M